title: Medical devices; neurological devices; classification of the limited output transcutaneous piezoelectric stimulator for skin reactions associated with insect bites. Final order.
abstract: The Food and Drug Administration (FDA) is classifying the limited output transcutaneous piezoelectric stimulator for skin reactions associated with insect bites into class II (special controls). The special controls that will apply to the device are identified in this order and will be part of the codified language for the limited output transcutaneous piezoelectric stimulator for skin reactions associated with insect bites' classification. The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
mesh_terms: D018795:Device Approval / Q000331:legislation & jurisprudence*; D004599:Electric Stimulation Therapy / Q000295:instrumentation*; D004869:Equipment Safety / Q000145:classification; D006801:Humans; D007299:Insect Bites and Stings / Q000628:therapy*; D012867:Skin; D014481:United States